solver.press

Integrating evolutionary trade-off models from microbiology with active foam physics simulations will enable prediction of spatial patterns in the spread of antibiotic-resistant bacterial colonies.

BiologyApr 22, 2026Evaluation Score: 66%

Adversarial Debate Score

70% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

Grok: The hypothesis is falsifiable through simulation and experimental validation of spatial patterns, and it is partially supported by papers on evolutionary trade-offs in antibiotic resistance and active matter physics. However, the integration of these distinct fields lacks direct evidence in the p...
Mistral: The hypothesis is falsifiable and integrates well-supported concepts (evolutionary trade-offs, active matter physics), but counterarguments exist—e.g., compensatory mutations or environmental heterogeneity could undermine predictive accuracy. The papers provide partial but not exhaustive support.
ChatGPT: The hypothesis is falsifiable and builds on well-supported concepts—evolutionary trade-offs in resistance and active matter physics—but the cited papers stop short of directly integrating these fields or demonstrating predictive spatial models, making the claim plausible yet not fully substantiat...

Supporting Research Papers

Computational Validation

📖 Literature-assessed (LLM) — not computational verification

Integration of models shows promise but requires further validation.

Method: literature_meta · Result: inconclusive · Confidence: 60%

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

A coupled model — comprising (a) an evolutionary trade-off model of antibiotic resistance (cost-of-resistance vs. growth rate, following classic fitness-cost frameworks) and (b) an active-foam/active-matter physics simulation (treating bacterial colonies as a jammed, actively-driven foam of growing/dividing cells with mechanical interactions) — will predict the spatial pattern of resistant subpopulation spread (front velocity, sector angle distribution, spatial heterogeneity index, and clustering coefficient) within a bacterial colony expanding on a solid or semi-solid antibiotic gradient substrate, to within 15% relative error against experimental colony imaging data, and will outperform (lower prediction error) both (i) a pure reaction-diffusion (Fisher-KPP) model without mechanical foam physics and (ii) a pure foam-mechanics model without evolutionary trade-off terms, on held-out experimental replicates.

Disproof criteria:
  • The coupled model's prediction error (RMSE on front velocity, sector angle distribution KL-divergence, or spatial heterogeneity index) is not statistically significantly better (p > 0.05, paired bootstrap test, n≥20 colony replicates) than the best single-mechanism baseline (pure reaction-diffusion or pure foam-mechanics-without-evolution).
  • Model requires per-replicate parameter refitting (rather than fitting once on a training set and generalizing) to achieve acceptable error, indicating lack of true predictive/generalization power.
  • Predicted sector/patch spatial statistics fall outside 2 standard deviations of experimental distributions in >50% of held-out test conditions.
  • Mechanical (foam) parameters and evolutionary (trade-off) parameters cannot be jointly identified/fit without degeneracy (i.e., multiple very different parameter sets give equally good fits — non-identifiability), undermining claims of mechanistic prediction rather than curve-fitting.

Spine & Adversarial ReadReady for validation

This hypothesis tests whether coupling an evolutionary fitness-cost model with active-foam mechanical simulation of bacterial colonies predicts spatial resistance-spread patterns more accurately than either mechanism alone.

  • highWhy model bacterial colonies as an 'active foam' specifically, rather than simpler agent-based models, continuum reaction-diffusion with density-dependent growth, or established biofilm models (e.g., cellular automata) — the methodology choice of foam physics over alternatives is not justified in the protocol.
    Partial justification: active-foam/vertex models capture jamming-induced growth inhibition and mechanical stress propagation that pure reaction-diffusion cannot, which is plausibly relevant to sector formation in dense colonies (supported by general active-matter literature on cell jamming, e.g., Bi/Manning-style vertex models). However, the EVP does not empirically justify foam physics over alternative mechanical formalisms (e.g., agent-based Brownian dynamics, phase-field models) before committing resources — this is a gap. A pre-registered model-comparison step against a third 'simple mechanical' baseline (not just pure diffusion) should be added to strengthen justification.
  • highThe fitness-cost parameters and mechanical parameters are both fit from data, creating a high-dimensional joint parameter space; achieving a good fit could reflect flexible curve-fitting rather than genuine mechanistic prediction, especially with limited replicate numbers (n=20-60).
    Addressed via explicit identifiability analysis (profile likelihood/MCMC) and train/test split with blind prediction as disproof criteria — this is a reasonable mitigation, but statistical power with n=20-60 replicates for a 10-20 parameter model is likely marginal; true resolution requires either parameter reduction (fixing more values from independent literature measurements) or substantially larger replicate counts, neither of which is fully budgeted here.
  • mediumResistance in real clinical/environmental settings is often driven by horizontal gene transfer (plasmids) and polygenic/epistatic effects, which are explicitly excluded from scope — so even a successful validation may have limited applicability to the clinically important cases motivating the Impact Statement.
    Explicitly acknowledged as a boundary condition/scope limitation; the EVP frames this as a first validated building block, not a complete clinical model, and lists HGT extension as future work rather than resolving it within this validation.

Experimental Protocol

Minimum viable test (MVT):

  1. Use published/available time-lapse colony expansion datasets (e.g., E. coli on antibiotic gradient agar, fluorescently labeled resistant vs. susceptible subpopulations) — target 3 independent published datasets or newly generated data from 20 replicate plates.
  2. Build baseline Model A (Fisher-KPP reaction-diffusion with resistance as a genotype fraction field, no mechanics) and baseline Model B (active foam mechanics, homogeneous genotype, no trade-off) as null comparators.
  3. Build integrated Model C: active foam/vertex-model mechanical layer (cell-cell forces, growth-induced pressure, jamming) coupled to a two-strain (or continuous trait) reaction-diffusion-selection layer parameterized by literature fitness-cost values (growth rate reduction 5–40% typical for resistance mutations) and local antibiotic concentration field.
  4. Fit each model's free parameters on 60% of replicate colonies (training set); freeze parameters; predict spatial pattern metrics on remaining 40% (test set), blind to genotype-labeling ground truth during prediction generation.
  5. Compare prediction error distributions (Model A vs B vs C) via paired statistical tests across test-set replicates.
  6. Run sensitivity/ablation: remove trade-off term from Model C (set fitness cost = 0) and remove mechanical jamming term (set to well-mixed diffusion) to isolate which component drives predictive gains.
Required datasets:
  • Time-lapse fluorescence/brightfield microscopy of bacterial colony expansion on antibiotic gradient plates (spatial resolution ≤10 µm/pixel, temporal resolution ≤30 min/frame, ≥24h duration) — e.g., data in style of Baym et al. MEGA-plate experiments (2016, Science) or equivalent lab-generated data.
  • Strain-specific fitness-cost measurements (growth rate vs. resistance level) from literature (e.g., Andersson & Hughes fitness-cost review datasets) or new competition assays.
  • Antibiotic concentration gradient calibration data (diffusion coefficients in agar, measured or literature values).
  • Cell mechanical parameters (Young's modulus of bacterial colonies, packing fraction, division rate distributions) from AFM/rheology literature or new measurement.
  • Image segmentation/tracking pipeline (e.g., Omnipose, DeLTA, or custom CNN segmenter) to extract genotype-spatial labels from raw imaging.
Success:
  • Model C achieves ≤15% relative error (RMSE normalized by observed range) on front velocity and sector angle distribution on held-out test replicates.
  • Model C outperforms both Model A and Model B with statistically significant margin (paired bootstrap p<0.05, effect size Cohen's d>0.5) on at least 2 of 4 spatial pattern metrics.
  • Parameters are identifiable: profile likelihood shows single well-defined optimum (no flat ridges spanning >1 order of magnitude in fitness-cost or mechanical stiffness parameters).
  • Results replicate across ≥2 independent antibiotic conditions and ≥1 independent bacterial species.
Failure:
  • Model C error not significantly different from Model A or B (p>0.05) on majority of metrics → hypothesis disproven as stated.
  • Non-identifiable parameter degeneracy persists after profile likelihood/MCMC analysis → coupling adds complexity without predictive/mechanistic value.
  • Model C requires substantially different (>3x) parameter values per replicate to fit — indicates overfitting rather than generalizable mechanism.
  • Predictions fail to generalize across species/conditions (only fits training species).

100

GPU hours

30d

Time to result

$1,000

Min cost

$10,000

Full cost

ROI Projection

Commercial:

Platform value for pharmaceutical antibiotic-stewardship software, biofilm-control medical device design (catheter coatings, wound dressings), agricultural antibiotic/pesticide resistance management, and academic tool licensing (active-matter simulation platform). Estimated addressable market: antibiotic stewardship decision-support software ($150-400M market segment) plus academic/pharma simulation licensing ($5-15M niche tool market). Medium-term commercial value estimate: $10-30M if translated into a clinical decision-support or R&D simulation product within 5 years.

TIME_TO_RESULT_DAYS: 270

Implementation Sketch

# Pseudocode outline

class FoamMechanicalLayer:
    # Vertex/particle-based model of growing, dividing cells
    def __init__(self, packing_fraction, division_rate, stiffness):
        ...
    def step(dt):
        compute_cell_cell_forces()
        update_positions_via_active_stress()
        handle_division_and_jamming()

class EvolutionaryTradeoffLayer:
    def __init__(self, fitness_cost, resistance_level, antibiotic_field):
        ...
    def local_growth_rate(cell, antibiotic_conc):
        base_rate = wildtype_growth_rate
        if cell.resistant:
            return base_rate * (1 - fitness_cost) * survival(antibiotic_conc, resistance_level)
        else:
            return base_rate * survival(antibiotic_conc, resistance=0)

class CoupledModel(FoamMechanicalLayer, EvolutionaryTradeoffLayer):
    def step(dt):
        antibiotic_field.diffuse(dt)
        for cell in cells:
            cell.growth_rate = local_growth_rate(cell, antibiotic_field.at(cell.pos))
            cell.mechanical_stress = compute_local_stress(cell)
            cell.growth_rate *= mechanical_inhibition(cell.mechanical_stress)  # jamming feedback
        FoamMechanicalLayer.step(dt)
        handle_stochastic_division_with_genotype_inheritance()

# Calibration
fit_parameters(CoupledModel, training_replicates, method="Bayesian MCMC or CMA-ES")
predictions = CoupledModel.simulate(test_conditions)
compare_spatial_statistics(predictions, experimental_test_data)
Abort checkpoints:
  • Checkpoint 1 (Day 30): If image segmentation/genotype classification pipeline achieves <85% accuracy against manual ground truth, halt and fix pipeline before proceeding.
  • Checkpoint 2 (Day 90): If Model A and Model B baseline implementations cannot achieve stable, converged simulations matching qualitative colony growth (front velocity within order of magnitude of experiment), halt and debug core simulation infrastructure.
  • Checkpoint 3 (Day 150): If parameter fitting for Model C shows severe non-identifiability (profile likelihood flat over >2 orders of magnitude) on training data alone, halt and reconsider model structure/parameterization before spending compute on blind test predictions.
  • Checkpoint 4 (Day 200): If Model C training-set fit error is not at least comparable to (not necessarily better than) Models A/B, do not proceed to full test-set validation — hypothesis likely fails.

NAMED_EXPERTS: []

CLOSEST_EXISTING_WORK: []

NOVELTY_NARROWING_REQUIRED: false

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started